Clinical Trials Logo
  1. Home
  2. Cocaine-Related Disorders
  3. NCT00000315
  4. Details
NCT00000315 Clinical Trial

Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1

Cocaine-Related Disorders Clinical Trial

Official title:
Human Dopamine Transported Imaging in Cocaine Abuse: 1

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00000315
Other study ID # NIDA-09482-1
Secondary ID R01-09482-1
Status Completed
Phase Phase 1
First received September 20, 1999
Last updated January 11, 2017
Start date November 1996
Est. completion date December 2001

Study information
Verified date November 1996
Source National Institute on Drug Abuse (NIDA)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the density of DA transporters during prolonged cocaine abuse and during withdrawal from cocaine use. This aim will test the hypothesis that DA transporters are altered by cocaine abuse and reestablished during withdrawal.

Recruitment information / eligibility
Status Completed
Enrollment 0
Est. completion date December 2001
Est. primary completion date
Accepts healthy volunteers No
Gender Male
Age group 21 Years to 45 Years
Eligibility Please contact site for information.

Study Design

Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Drug:
• Cocaine

Locations
Country Name City State
United States Johns Hopkins University Baltimore Maryland

Sponsors (2)
Lead Sponsor Collaborator
National Institute on Drug Abuse (NIDA) Johns Hopkins University

Country where clinical trial is conducted

United States, 

References & Publications (1)

JNM Suppl 38(5):35P May 97.

Outcome
Type Measure Description Time frame Safety issue
Primary Physiological changes in: heart rate and blood pressure
Primary Subjective effects of cocaine inducements and withdrawal
Primary Psychological effects
Primary Effects of investigational drug
See also
  Status Clinical Trial Phase
Completed NCT01526538 - Improving Learning-based Treatment of Cocaine Dependence With Medication Phase 2
Completed NCT00877435 - Prize Reinforcement Contingency Management for Cocaine Dependence: a 24-week Randomized Controlled Trial N/A
Completed NCT00430690 - Acoustic Startle Reduction In Cocaine Dependence
Completed NCT00217997 - Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals N/A
Active, not recruiting NCT00094315 - Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1 Phase 1
Terminated NCT00142883 - The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3 N/A
Completed NCT00218348 - Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo Phase 2
Completed NCT00158132 - Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2 Phase 2
Completed NCT00142844 - Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1 Phase 2
Completed NCT00000294 - Effects of Carvedilol on Cocaine Use in Humans - 11 Phase 2
Completed NCT00015054 - Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3 Phase 2
Completed NCT00000308 - Dextroamphetamine-Cocaine Behavioral Intervention - 5 Phase 2
Completed NCT00000277 - Mazindol for Cocaine Abuse - 2 Phase 2
Completed NCT00000280 - Glutaminergic Agents for Cocaine Abuse - 5 Phase 1
Terminated NCT00000276 - Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 Phase 1
Completed NCT00000278 - Disulfiram for Cocaine-Alcohol Abuse - 3 Phase 2
Completed NCT00000188 - Selegiline in Treatment of Cocaine Dependence - 2 Phase 2
Completed NCT00000282 - Pemoline for Cocaine Abuse - 7 Phase 2
Completed NCT00000314 - M-CPP and Fenfluramine in Cocaine Addicts - 3 Phase 2
Completed NCT00000306 - Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3 Phase 2